United States: PTAB Awards Priority For CRISPR-Cas9 Systems In Eukaryotic Cells To Broad Institute, MIT And Harvard - Akin Gump Strauss Hauer & Feld LLP

In its latest decision in a series of interferences related to the CRISPR gene-editing system, the Patent Trial and Appeal Board (PTAB) granted priority to The Broad Institute, MIT and Harvard (collectively, "Broad")...